EPO has been founded in 1997 as a spin-off from the Max-Delbrück-Center for Molecular Medicine [MDC] in Berlin Buch and is celebrating its 25th business anniversary this year. Since 1997 EPO has grown steadily and today has a loyal customer base of more than 450 clients worldwide. Get in touch with us to find out how your research projects can profit from our 25 years of experience with patient-derived xenografts and our comprehensive immuno-oncology pipeline!
